Serum MicroRNAs as Diagnostic Biomarkers of Colorectal Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorBishoy Shehata
About this trial
evaluation the diagnostic value of certain MicroRNAs as biomarkers of Colorectal cancer by comparing its expression levels in Colorectal cancer patients and normal individuals.
Eligibility criteria
Qualifiers
Adults (age 18-75) diagnosed with primary CRC (histopathologically confirmed).
CRC patients who have not received prior treatment (i.e., chemotherapy or radiation).
Age-matched healthy controls without colorectal disease
Disqualifiers
Patients with secondary tumors or metastasis originating from non-colorectal sources.
Patients with prior history of CRC.
Patients who refuse to contribute in this study.
Trial design
Treatments tested in this trial
- certain serum MicroRNA biomarkers (miR-15b and miR-21)
Treatment groups
80 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Bishoy Shehata
Lead sponsor
Assiut University
Sponsor institution
Source ClinicalTrials.gov